Exercise Prescriptions for Cancer Patients Mapped: Tai Chi, HIIT and Combined Training Top the Rankings

For millions of people living with and beyond cancer, exercise has become one of the most consistently supported non-drug interventions for improving day-to-day wellbeing. Yet the practical question that patients, oncologists and rehabilitation specialists face is rarely whether to prescribe movement, but which kind of movement, and how much of it. A new systematic review and meta-analysis published in BMC Cancer by researchers at Shanghai University of Sport and Hebei Sport University set out to answer precisely that, combining two of the most powerful statistical tools in evidence synthesis to compare exercise modalities head to head and to model how the dose of exercise relates to improvements in quality of life.

The research team, led by Zhengxin Hui and Liang Li, who contributed equally to the work, and supervised by Yinping Zhang and Tonggang Fan, conducted systematic searches of PubMed, Web of Science, Embase and the Cochrane Library up to August 2026. From these searches they assembled an unusually large evidence base: 149 randomized controlled trials encompassing 13,004 patients with cancer. Randomized controlled trials are considered the gold standard for estimating causal effects because participants are assigned by chance to an intervention or a comparison group, which balances out the confounding factors that plague observational studies. Pooling 149 of them therefore offers one of the most comprehensive pictures to date of how different exercise prescriptions perform in cancer populations.

What makes this study methodologically distinctive is its dual approach. First, the authors performed a Bayesian network meta-analysis, a technique that goes beyond traditional pairwise meta-analysis by allowing every intervention to be compared with every other intervention, both directly, when trials tested two modalities against each other, and indirectly, when trials linked them through a common comparator such as usual care. This creates a network of evidence in which the relative standing of each exercise type can be estimated even if no single trial ever compared them all in one experiment. To rank the interventions, the team used the surface under the cumulative ranking curve, or SUCRA, a metric that runs from zero to 100 percent and expresses the probability that a given treatment ranks highest among all the options evaluated.

The SUCRA rankings produced a clear shortlist of top performers. Qigong and Tai Chi, the slow, flowing mind-body practices rooted in traditional Chinese movement culture, emerged among the highest-ranked interventions, alongside high-intensity interval training, better known as HIIT, and combined aerobic and resistance training. The prominence of Qigong and Tai Chi is striking because these are low-impact, low-load practices that many patients with advanced disease, fatigue or treatment-related limitations can actually perform. Their high ranking suggests that the gentle, rhythmic, breath-coordinated character of these practices may deliver quality-of-life benefits that rival far more strenuous regimens, a finding with immediate relevance for patients who cannot tolerate intense exercise.

HIIT, by contrast, represents the opposite end of the intensity spectrum. It alternates short bursts of near-maximal effort with recovery periods, and it has attracted growing interest in exercise oncology because it achieves substantial cardiovascular and muscular stimulus in a compressed amount of time. Combined aerobic and resistance training, the third top-ranked modality, blends endurance work such as walking or cycling with strength work using weights or bodyweight resistance. The convergence of these three very different modalities at the top of the rankings underscores an important point: there is no single best exercise for quality of life in cancer care, but rather several distinct pathways, each with its own dose requirements, that appear to lead to similar destinations.

The second analytical pillar of the study was a network dose-response meta-analysis, abbreviated MBNMA in the paper, which models how the effect of an intervention changes as a function of its dose. The researchers quantified exercise dose using MET-minutes per week, a standard unit in exercise science in which one metabolic equivalent, or MET, represents the energy cost of resting quietly, and brisk physical activity typically registers at three to eight METs. A person walking briskly for five hours a week at roughly four METs would accumulate about 1,200 MET-minutes. Rather than assuming that more exercise is always better, the team fitted an Emax model, a nonlinear function borrowed from pharmacology that describes how a response rises with dose, approaches a maximum, and then plateaus.

The dose-response modelling delivered one of the study’s headline findings: the association between exercise dose and quality of life is nonlinear, with the model-estimated overall effect peaking at approximately 2,000 MET-minutes per week. Below that threshold, additional exercise appears to buy meaningful gains in wellbeing; beyond it, the model suggests diminishing returns. This kind of plateau is biologically plausible. Quality of life is constrained not only by physical capacity but by fatigue, psychological distress, sleep and social functioning, and once exercise has extracted the improvements it can deliver in these domains, pushing the dose higher may add strain without adding benefit. The finding echoes the shape of dose-response curves reported in other exercise-oncology research and gives clinicians a concrete numerical anchor for prescription.

Crucially, the peak dose was not the same for every modality. The model-estimated maximum effect for Qigong and Tai Chi occurred at a much lower dose, around 750 MET-minutes per week, which corresponds to only a few hours of gentle practice spread across the week. HIIT reached its model-estimated maximum at about 800 MET-minutes per week, consistent with the idea that high-intensity work delivers its stimulus efficiently. Combined aerobic and resistance training required the largest dose, with the model placing its maximum effect at roughly 2,000 MET-minutes per week, in line with the overall peak. In practical terms, a patient who enjoys and tolerates combined training may need to invest considerably more weekly activity to reach the modelled optimum, whereas a patient drawn to mind-body practice or interval work may achieve comparable modelled benefit at a fraction of that volume.

The authors are careful to frame these estimates as model-derived values that require prospective validation. Network meta-analysis and dose-response modelling are observational in the sense that they reanalyse existing trial data rather than testing prescriptions in new patients, and the Emax parameters depend on the doses represented in the included trials, which were not designed with a common dose grid in mind. Heterogeneity across cancer types, treatment stages, outcome instruments and intervention durations can all influence the pooled estimates, and the Bayesian framework makes its assumptions explicit but does not eliminate them. The study was funded by the Shanghai Oriental Talent Program Youth Project, and the authors declare no competing interests. The work is published open access, making the full analysis available to clinicians and researchers worldwide.

Even with those caveats, the study arrives at a moment when exercise is being formally integrated into cancer care pathways in many health systems, and it offers something those pathways have lacked: a comparative, quantified map of the options. For a patient beginning rehabilitation after chemotherapy, the findings suggest that a low-dose Qigong or Tai Chi routine may be an evidence-supported starting point, particularly when fatigue or deconditioning makes vigorous activity unappealing. For a fitter patient, HIIT or a combined aerobic and resistance program, dosed with the modelled peaks in mind, represents an alternative route to the same goal. What the analysis ultimately reinforces is that in exercise oncology, as in pharmacology, the prescription matters, the dose matters, and the best regimen is the one that matches the right modality to the right patient at the right intensity.

Subject of Research: Comparative effectiveness and dose-response of exercise interventions on quality of life in patients with cancer

Article Title: Optimizing exercise regimens for quality of life in patients with cancer: a network meta-analysis and dose–response study

Article References: Hui, Z., Li, L., Zhang, Y., & Fan, T. (2026). Optimizing exercise regimens for quality of life in patients with cancer: a network meta-analysis and dose–response study. BMC Cancer. https://doi.org/10.1186/s12885-026-17109-5

Image Credits: AI Generated

DOI: 10.1186/s12885-026-17109-5

Keywords: cancer rehabilitation, exercise oncology, quality of life, network meta-analysis, dose-response, HIIT, Tai Chi, Qigong, aerobic training, resistance training, randomized controlled trials, SUCRA